<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T16:19:00.7808776+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-NGA-T-IHVN-3</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Investing for impact against Tuberculosis and HIV - Nigeria (01-Jul-2015-31-Dec-2018)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Nigeria, the most populous African nation, ranks 4th among the high tuberculosis (TB) burden countries in the world, according to the 2009 WHO Global TB Report, and first in Africa with an estimated 460,000 new cases annually. TB constitutes a considerable public health problem: in 2007, the national TB Program reported 2,189 TB patient deaths. The TB burden is borne by the entire population, but especially by higher risk populations, such as the urban and rural poor, people living with HIV/AIDS (PLWHA) and those in congregate settings including prison inmates, armed forces personnel, and socially marginalized and displaced persons. There is also a significant socio-economic consequence of TB in Nigeria, as the disease is most prevalent among the most economically productive age range of 15-45 years.   In 2010 the WHO estimates, that there were an estimated 11,000 (95% C.I. 1,300-20,000) MDR-TB cases in Nigeria in 2008, based on expected incidence. This corresponds to an estimated MDR-TB rate of 1.8% (95% C.I. 0.0-4.3) among new cases and 7.7% (95% C.I. 0.0-18.1) among retreatment cases. However based on notified pulmonary TB cases in 2009 the best estimate of MDR cases are 1,900 (95% C.I. 600 – 3,900).   This Program aims to reduce the TB burden by complementing and accelerating the ongoing activities implemented by government, partners, including USAID, and through the Global Fund Round 5 program (NGA-509-G15-T). In particular, the focus of this Program is to strengthening the MDR TB program implementation.    This Program implements the remaining components of the Round 9 TB proposal.  That proposal was designed to be “split” into two grants to be implemented by two principal recipients. The DOTS expansion and TB/HIV component was signed in September 2010 with the Association for Reproductive and Family Health (ARFH).   The second part of the proposal with the MDR-TB component was not signed due to challenges associated with identifying a principal recipient that met minimum capacity requirements. The CCM nominated one principal recipient in mid-2009 which underwent LFA assessments but which regrettably did not meet minimum requirements. The CCM subsequently launched an open and transparent procedure, based on Global Fund policies, to identify a new principal recipient. Based on this process, the CCM nominated the Institute of Human Virology Nigeria (IHVN) as the Principal Recipient and on 15 December 2010, IHVN was selected as Principal Recipient for this Grant.   On 26 March 2010, The Technical Review Panel approved the MDR-TB component of the proposal for a patient cohort of 80 patients (Initial MDR-TB Approval).  The CCM with assistance of the WHO TB Team and the Green Light Committee, has also prepared a reprogramming request to the Technical Review Panel of the Global Fund (TRP) to support scale-up and required health system strengthening (HSS) of the MDR-TB program to address previous TRP concerns raised during the  TRP clarification process. The TRP has approved the reprogramming request on 23 June 2011 (Scale Up).  The Global Fund Board approved a 3 month extension to the signing deadline for this Grant until 20 May 2011 (B22/ER/02).  This Grant will also be signed as a SSF grant, fully aligned with the Round 9 TB grant with ARFH (DOTS and TB/HIV).</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<other-identifier ref="NGA-T-IHVNP03" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2015-07-01" />
		<activity-date type="2" iso-date="2015-07-01" />
		<activity-date type="3" iso-date="2018-12-31" />
		<activity-date type="4" iso-date="2018-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Jean, NOUBOUSSI</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>jean.nouboussi@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="NG" percentage="100">
			<narrative xml:lang="en">Nigeria</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12263" percentage="100">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<transaction ref="9f09242c-cc6b-4acc-9a36-98001f979b95">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-11-20" />
			<value currency="USD" value-date="2017-11-20">7609903.09</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="45a8d35a-cb9b-4205-9e44-ba8ca8c47bb2">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-02-25" />
			<value currency="USD" value-date="2020-02-25">-6662630.66</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2e0b3747-267c-4aab-a40e-d0f5d58c9614">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-10-23" />
			<value currency="USD" value-date="2020-10-23">-27124.65</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="188dacc5-bac8-4a11-be3c-7039b28f0f33">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-03-01" />
			<value currency="USD" value-date="2018-03-01">16843808.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a6a40702-7cf6-40df-b8f5-ee7b266140a9">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-07-26" />
			<value currency="USD" value-date="2017-07-26">-6287196.42</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="76d7c570-22cb-43a2-842d-4d20491834d4">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-07-26" />
			<value currency="USD" value-date="2017-07-26">8779064.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3162e5ab-6c95-4461-8cab-ba27d95d3918">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-07-19" />
			<value currency="USD" value-date="2018-07-19">-8593571.19</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7d18b682-d338-4861-b61f-baee01c2dd85">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-04-10" />
			<value currency="USD" value-date="2018-04-10">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cc288d85-24bf-43e0-8cd4-3394b71b465f">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-07-10" />
			<value currency="USD" value-date="2020-07-10">-678249.81</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="757250c7-1add-41ff-aa69-0fe20340ee35">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-12-13" />
			<value currency="USD" value-date="2017-12-13">-850646.87</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4e2ff355-146e-4e5a-8541-690eb6f9225b">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-12-13" />
			<value currency="USD" value-date="2017-12-13">3877506.53</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="82a0b1f9-fd74-4973-bb3f-2122bcbfa7e3">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-12-15" />
			<value currency="USD" value-date="2017-12-15">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c2e73eaf-1e24-4fa8-81f6-f705bb00345b">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-12-07" />
			<value currency="USD" value-date="2018-12-07">-6688.89</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="147c7f4e-3f9c-43ac-acbf-9d1bdbaf90f6">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-07-19" />
			<value currency="USD" value-date="2018-07-19">15147220.23</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f6e11c3d-e94b-499e-b674-7850e842f71a">
			<transaction-type code="2" />
			<transaction-date iso-date="2016-02-22" />
			<value currency="USD" value-date="2016-02-22">32253317.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f7c8b602-5ce5-4a5b-a0b1-b284ed7150fa">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-11-20" />
			<value currency="USD" value-date="2017-11-20">-1674492.09</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e3448428-f91f-46bb-99d8-02e0ab65b085">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-08-07" />
			<value currency="USD" value-date="2018-08-07">18171.82</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b9462da8-c452-44fc-9794-a4417d348aaf">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-12-15" />
			<value currency="USD" value-date="2017-12-15">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="07cdc47f-2967-4963-ac1b-f3a6714c0012">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-07-04" />
			<value currency="USD" value-date="2017-07-04">1471579.37</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c40f2541-ebde-42dc-8e76-421dcc45ebcf">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-09-22" />
			<value currency="USD" value-date="2016-09-22">300130.57</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="983f0000-ae7f-40fb-8c8c-8e4db6d7143a">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-07-27" />
			<value currency="USD" value-date="2017-07-27">3111659.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="904b4e2f-a2f8-4c5f-867c-3ff3798fd126">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-04-11" />
			<value currency="USD" value-date="2016-04-11">572121.73</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="71f7acf5-56d5-4350-9159-fea642ca053a">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-09-15" />
			<value currency="USD" value-date="2016-09-15">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="36e29fef-b885-4a73-8419-d0116654b4e4">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-04-15" />
			<value currency="USD" value-date="2016-04-15">132369.33</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5747dfb9-a2b4-4e90-b062-9adad060e6c6">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-12-05" />
			<value currency="USD" value-date="2017-12-05">19879.22</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="22aa2279-a648-4a0e-be98-b4be6d9f6137">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-02-14" />
			<value currency="USD" value-date="2017-02-14">55612.21</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="98345c12-bf43-4a85-8755-03e8ed10b8b0">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-09-15" />
			<value currency="USD" value-date="2016-09-15">4351947.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="387a7069-8671-4c69-be41-3f65078c570e">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-03-02" />
			<value currency="USD" value-date="2018-03-02">32182.51</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c72200e0-58d5-4934-95e3-7155b62b06e7">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-12-14" />
			<value currency="USD" value-date="2017-12-14">1563527.27</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="aa349034-fb94-44d5-9ba6-dd5a269a5e95">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-02-14" />
			<value currency="USD" value-date="2017-02-14">461546.08</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="66f19051-8288-4269-aad3-46417e111115">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-09-22" />
			<value currency="USD" value-date="2017-09-22">2307693.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6ee2a5e3-cf38-433e-ac4c-66fe2cf31820">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-12-31" />
			<value currency="USD" value-date="2018-12-31">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fd56e891-8889-448a-8160-8c196b171370">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-09-22" />
			<value currency="USD" value-date="2017-09-22">1685219.91</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4d263fb2-8078-4802-a63e-72ce1c1db5ee">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-07-20" />
			<value currency="USD" value-date="2018-07-20">1265661.06</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="67af9adb-fa5d-4c7d-96f2-d97d400fab33">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-07-04" />
			<value currency="USD" value-date="2017-07-04">67451.48</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="71a62f8c-8f0f-4848-9ced-4fd7460b9790">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-03-02" />
			<value currency="USD" value-date="2018-03-02">2224810.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="20cae0fb-4fde-4a73-b00f-6d65251ea394">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-08-07" />
			<value currency="USD" value-date="2018-08-07">4461521.74</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ac10bceb-ba22-4bb3-96fd-0fea1c7d4a01">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-11-08" />
			<value currency="USD" value-date="2018-11-08">1604229.10</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5466e54b-7bd3-47e2-b733-2e7e5011f48c">
			<transaction-type code="7" />
			<transaction-date iso-date="2020-10-16" />
			<value currency="USD" value-date="2020-10-16">-27124.65</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1d67c34e-12c6-48b3-9538-b59fdf233e9c">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-07-04" />
			<value currency="USD" value-date="2017-07-04">41362.53</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="004fdb38-fd6f-42d5-b07f-75154c66d332">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-12-14" />
			<value currency="USD" value-date="2017-12-14">2313979.26</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c1b3440a-d3b9-4e05-ba0a-f34435094a64">
			<transaction-type code="7" />
			<transaction-date iso-date="2020-07-06" />
			<value currency="USD" value-date="2020-07-06">-678249.81</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2db610dd-bd5a-421f-9b17-3519fc6167b9">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-12-18" />
			<value currency="USD" value-date="2018-12-18">8984.63</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="17460840-b7d0-4fd6-a439-25b73a8e4b1c">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-05-11" />
			<value currency="USD" value-date="2017-05-11">677788.15</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cbd3ede6-0dba-43d4-a4a5-40aab709a58f">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-02-23" />
			<value currency="USD" value-date="2016-02-23">3676306.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f3eb198a-2d15-460d-a68b-2c794920531a">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-11-21" />
			<value currency="USD" value-date="2017-11-21">6739377.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6885f308-6811-42d1-8f6d-9c88945c66f2">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-03-15" />
			<value currency="USD" value-date="2016-03-15">336832.90</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3231db9c-9c95-4b36-b197-ce454b7ef414">
			<transaction-type code="7" />
			<transaction-date iso-date="2018-12-07" />
			<value currency="USD" value-date="2018-12-07">-6688.89</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5d70f34d-3616-4966-b296-039e801686fd">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-06-05" />
			<value currency="USD" value-date="2018-06-05">1073436.30</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b145c65a-8a5d-4a08-a31a-b7f0db5ac93e">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-12-11" />
			<value currency="USD" value-date="2018-12-11">1126021.22</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b7e108de-3b1b-457e-aa90-1e9b312e6b06">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-04-26" />
			<value currency="USD" value-date="2018-04-26">4919808.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8ab4c052-6730-4287-88cd-0f4af78ab3c2">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-03-16" />
			<value currency="USD" value-date="2017-03-16">7786328.16</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5110f086-d893-40ba-ae81-b4e806ee41d5">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-01-24" />
			<value currency="USD" value-date="2017-01-24">5965903.63</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="57127201-ad15-4345-9e76-44a1fcf5adac">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-03-16" />
			<value currency="USD" value-date="2017-03-16">18841.44</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/NGA-T-IHVN" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for NGA-T-IHVNP03</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">MDR TB-other 1: Number of cases with drug resistant TB (RR-TB and/or MDR-TB) that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="710" />
					<actual value="1251" />
				</period>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="355" />
					<actual value="569" />
				</period>
				<period>
					<period-start iso-date="2015-07-01" />
					<period-end iso-date="2015-12-31" />
					<target value="285" />
					<actual value="382" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="1590" />
					<actual value="1895" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="795" />
					<actual value="884" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="1910" />
					<actual value="1786" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="955" />
					<actual value="872" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="2200" />
					<actual value="1158" />
				</period>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="1326" />
					<actual value="767" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="5337" />
					<actual value="2275" />
				</period>
				<period>
					<period-start iso-date="2015-07-01" />
					<period-end iso-date="2015-12-31" />
					<target value="2158" />
					<actual value="775" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="4400" />
					<actual value="2286" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="2651" />
					<actual value="1686" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="2668" />
					<actual value="1037" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="1870" />
					<actual value="1520" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="5337" />
					<actual value="1895" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="7900" />
					<actual value="4484" />
				</period>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="3950" />
					<actual value="4649" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="2668" />
					<actual value="884" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="3740" />
					<actual value="1786" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="100.00" />
					<actual value="87.50" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="100.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2015-07-01" />
					<period-end iso-date="2015-12-31" />
					<target value="100.00" />
					<actual value="0.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">MDR TB-other 2: Percentage of presumptive DR-TB cases that received tesing for DR-TB (RR-TB and/or MDR-TB)</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="1870" />
					<actual value="46.60" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="2121" />
					<actual value="1251" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="50.00" />
					<actual value="50.00" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="60.00" />
					<actual value="54.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="10488" />
					<actual value="31.90" />
				</period>
				<period>
					<period-start iso-date="2015-07-01" />
					<period-end iso-date="2015-12-31" />
					<target value="100.00" />
					<actual value="78.60" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for NGA-T-IHVNP03</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate - bacteriologically confirmed TB cases</narrative>
				</title>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="87.00" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="89.00" />
					<actual value="85499" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB O-Other 1: Percentage of culture positive DR-TB cases who have a negative culture at the end of eight month treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="65.00" />
					<actual value="76.00" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="67.00" />
					<actual value="79.00" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="69.00" />
					<actual value="74.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="153" />
					<actual value="54" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="90.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="54.00" />
					<actual value="24.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="77.00" />
					<actual value="78.00" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for NGA-T-IHVNP03</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB/HIV mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="9" />
					<actual value="21" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="7" />
					<actual value="18" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB prevalence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="308" />
					<actual value="337" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="4.20" />
					<actual value="4.30" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-NGA-T-IHVN-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Tuberculosis - Nigeria (01-Jun-2011-31-Dec-2012)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Nigeria, Tuberculosis, Institute of Human Virology Nigeria (IHVN)</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<other-identifier ref="NGA-T-IHVNP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2011-06-01" />
		<activity-date type="2" iso-date="2011-06-01" />
		<activity-date type="3" iso-date="2012-12-31" />
		<activity-date type="4" iso-date="2012-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Jean, NOUBOUSSI</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>jean.nouboussi@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="NG" percentage="100">
			<narrative xml:lang="en">Nigeria</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12263" percentage="100">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<transaction ref="caef2d30-f680-4e2d-8440-d2583e4d901d">
			<transaction-type code="2" />
			<transaction-date iso-date="2011-06-01" />
			<value currency="USD" value-date="2011-06-01">5585282.85</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="649610da-104c-4c9b-aea3-a4373710d986">
			<transaction-type code="3" />
			<transaction-date iso-date="2011-07-08" />
			<value currency="USD" value-date="2011-07-08">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a7356e64-c045-469d-9360-4efca29c0618">
			<transaction-type code="3" />
			<transaction-date iso-date="2012-08-06" />
			<value currency="USD" value-date="2012-08-06">2265996.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="db520d0c-a826-4992-9957-9ecbb6c91131">
			<transaction-type code="3" />
			<transaction-date iso-date="2011-07-07" />
			<value currency="USD" value-date="2011-07-07">3219286.85</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d753a022-8ebf-497a-ad61-437fc4ce9159">
			<transaction-type code="3" />
			<transaction-date iso-date="2012-08-06" />
			<value currency="USD" value-date="2012-08-06">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/NGA-T-IHVN" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-NGA-T-IHVN-5</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Investing for impact against Tuberculosis- Scaling up Private Sector participation in TB Control - Nigeria (01-Jan-2021-31-Dec-2023)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Nigeria, Tuberculosis, Institute of Human Virology Nigeria (IHVN)This program has the following goals: To accelerate efforts at ending TB epidemic in Nigeria by ensuring access to comprehensive and high quality patients' centered and community owned TB (TB. TB/HIV and DR-TB) services for all Nigerians by 2025.  To increase the PPM contribution to the National TB case notification from 14% in 2019 to 35% in 2023. The objectives of this program are: Coverage: 1a) Increase FBOs engaged in TB services from 81% to 100% 1b) Maintain PFPs engaged in TB services at 15%  1c) Maintain the standalone laboratories engaged in TB services at 19% 1d) Maintain PMVs, CPs &amp; TBAs/Religious houses engaged in TB referral at 38%.  Diagnosis: 2a) Notify 213,212 new TB cases 2b) Notify 7,356 DR TB cases 2c) Increase childhood TB cases notified to 15% of all notified TB cases  2d) Clinically screen 100% of OPD attendees at private facilities.  Treatment and Prevention: 3a) Place 100% of notified DR TB cases on treatment 3b) Increase the under 5 childhood contacts of TB cases on IPT to 100%  3c) Attain 90% Treatment Success Rate by 2023</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<other-identifier ref="NGA-T-IHVNP05" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="4" />
		<activity-date type="1" iso-date="2021-01-01" />
		<activity-date type="2" iso-date="2021-01-01" />
		<activity-date type="3" iso-date="2023-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Jean, NOUBOUSSI</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>jean.nouboussi@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="NG" percentage="100">
			<narrative xml:lang="en">Nigeria</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12110" percentage="18">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="3">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="79">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="18">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="9">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="64">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2022-01-01" />
			<period-end iso-date="2022-12-31" />
			<value currency="USD" value-date="2021-01-01">26341199.86</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2021-01-01" />
			<period-end iso-date="2021-12-31" />
			<value currency="USD" value-date="2021-01-01">7114152.67</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2023-01-01" />
			<period-end iso-date="2023-12-31" />
			<value currency="USD" value-date="2021-01-01">19793216.94</value>
		</budget>
		<transaction ref="7f63a85c-141d-46c0-bcb8-d04067cce8d2">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-06-27" />
			<value currency="USD" value-date="2025-06-27">-1760547.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1a75b2aa-d0d6-4feb-a5d2-2de4b5848374">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-12-15" />
			<value currency="USD" value-date="2020-12-15">20147956.47</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b84a0886-f351-46a0-bda1-a08d7c73f2bc">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-06-30" />
			<value currency="USD" value-date="2023-06-30">-901963.86</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5224bf5d-449c-4548-b254-27407620507f">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-10-18" />
			<value currency="USD" value-date="2022-10-18">-6884987.96</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="31aa9467-1b0e-4668-83bd-1ba30ef4a827">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-10-18" />
			<value currency="USD" value-date="2022-10-18">14431290.36</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cc723e76-61f7-4205-8d2b-9050da86759c">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-04-26" />
			<value currency="USD" value-date="2023-04-26">-1078.19</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7e56d01a-5192-4625-8a46-852dab28dcdf">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-12-20" />
			<value currency="USD" value-date="2021-12-20">-12448047.57</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ed8065f8-80c2-4811-b46c-1117c2094ec6">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-04-26" />
			<value currency="USD" value-date="2024-04-26">-6659.22</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9b287717-60ad-404e-8b14-7616ee201720">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-09-20" />
			<value currency="USD" value-date="2023-09-20">-37042.59</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="386ae209-9630-4f91-961c-1fd442cbc3b7">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-12-20" />
			<value currency="USD" value-date="2021-12-20">29621678.57</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ddc6ddd8-90c4-4ba3-8a36-1c8b2f484fb5">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-07-12" />
			<value currency="USD" value-date="2023-07-12">-10041.85</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1b175ecd-66c6-40d7-baac-103dca3761ba">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-06-30" />
			<value currency="USD" value-date="2023-06-30">4601151.28</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="55ee8c81-fc89-41a2-bed2-c72f538e2605">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-02-22" />
			<value currency="USD" value-date="2023-02-22">-46855.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fdb3c6f2-41a4-4b3b-b329-3a752c49179b">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-09-09" />
			<value currency="USD" value-date="2024-09-09">-779437.28</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cf1c6682-a9eb-49df-810f-f4067068a33d">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-09-09" />
			<value currency="USD" value-date="2024-09-09">24854.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="49310713-9a56-4e00-b158-2359f35ed7a9">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-12-15" />
			<value currency="USD" value-date="2022-12-15">-1953.24</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="61a2a58f-5fae-482b-b0e4-31a01c9949b4">
			<transaction-type code="7" />
			<transaction-date iso-date="2023-07-01" />
			<value currency="USD" value-date="2023-07-01">-10041.85</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6146f75c-92ca-4e2b-b0e5-bb0394dc65eb">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-19" />
			<value currency="USD" value-date="2022-12-19">779322.90</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4c152f4c-14e7-444d-99e3-2b8a17dbce1a">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-01-27" />
			<value currency="USD" value-date="2022-01-27">12065.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="79796f46-4425-43ec-a508-3e78feb54630">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-07-08" />
			<value currency="USD" value-date="2021-07-08">17902.50</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0e1e3b60-c50b-4f0c-9b89-d6f698a6df41">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-10-20" />
			<value currency="USD" value-date="2022-10-20">1016211.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="45f6a110-0727-4ed7-b913-70cb4a1f293b">
			<transaction-type code="7" />
			<transaction-date iso-date="2023-02-17" />
			<value currency="USD" value-date="2023-02-17">-46855.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9e2dd771-c2c8-4e14-aa96-5ddc8d0614c6">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-19" />
			<value currency="USD" value-date="2022-12-19">4921.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1ef9139d-f0bc-47ca-a17e-fa990a6cd39a">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-05-25" />
			<value currency="USD" value-date="2023-05-25">24044.77</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ef68dfa0-c1fb-4d50-8f48-adae936d6d43">
			<transaction-type code="7" />
			<transaction-date iso-date="2025-06-30" />
			<value currency="USD" value-date="2025-06-30">-1760547.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c1098a0e-a5b6-475c-897e-ce3a743a605f">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-12-21" />
			<value currency="USD" value-date="2021-12-21">18013631.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1be83f41-0bfd-4175-9979-da7cbb42b481">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-01-13" />
			<value currency="USD" value-date="2021-01-13">1622863.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d7ec5504-5196-4ebd-b93b-b09896199855">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-12-20" />
			<value currency="USD" value-date="2023-12-20">1734732.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c2caaec4-c55c-4051-a248-b9ace7af75bd">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-10-20" />
			<value currency="USD" value-date="2022-10-20">11193.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1cecaff5-4679-4909-8f38-79dcfa967427">
			<transaction-type code="7" />
			<transaction-date iso-date="2023-04-12" />
			<value currency="USD" value-date="2023-04-12">-1078.19</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="17581846-13ed-4d17-9795-f75426e25366">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-09-05" />
			<value currency="USD" value-date="2023-09-05">12981.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d2b6691f-7938-4fb9-9725-7866ff01d083">
			<transaction-type code="7" />
			<transaction-date iso-date="2022-12-01" />
			<value currency="USD" value-date="2022-12-01">-1953.24</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a7729d99-664f-4aa1-a8ac-2111e8531c97">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-06-16" />
			<value currency="USD" value-date="2022-06-16">4699801.61</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="dce5eedf-5fb9-4363-bcae-d099b4830e9e">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-09-05" />
			<value currency="USD" value-date="2023-09-05">2061020.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f50ab525-bc70-41eb-8651-a13d49a242da">
			<transaction-type code="7" />
			<transaction-date iso-date="2024-04-12" />
			<value currency="USD" value-date="2024-04-12">-6659.22</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="64145c64-e262-4acf-b590-1a4d670bddc4">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-11-25" />
			<value currency="USD" value-date="2021-11-25">2853382.90</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6c36b4ec-46af-42fd-b897-3eb196057d2b">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-09-12" />
			<value currency="USD" value-date="2024-09-12">24854.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2038aeb8-0961-48d3-aff9-283e226ab078">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-06-24" />
			<value currency="USD" value-date="2021-06-24">393212.50</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ad0b99e4-35b7-4563-b7c2-a9ec9bbdc51b">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-08-25" />
			<value currency="USD" value-date="2022-08-25">11193.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7dc498e0-d615-4dc1-b9f3-0e31e80c5445">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-10-20" />
			<value currency="USD" value-date="2022-10-20">387813.77</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b8c5b9ff-53b3-4a5d-8dee-b3dbfccb8949">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-07-04" />
			<value currency="USD" value-date="2023-07-04">12981.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ed8b2bfe-ac98-48f1-85cc-63ddb3462e95">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-07-08" />
			<value currency="USD" value-date="2021-07-08">2812548.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="baa4c9f0-c158-480e-bfd5-a62f9306b49d">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-19" />
			<value currency="USD" value-date="2022-12-19">11305820.06</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="295a9d0c-3bf5-48d5-8015-1788dc7622e5">
			<transaction-type code="7" />
			<transaction-date iso-date="2023-09-08" />
			<value currency="USD" value-date="2023-09-08">-37042.59</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP05.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/NGA-T-IHVN" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for NGA-T-IHVNP05</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1208" />
					<actual value="188" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="3162" />
					<actual value="377" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="889" />
					<actual value="143" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="889" />
					<actual value="128" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="1778" />
					<actual value="271" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1581" />
					<actual value="181" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="1208" />
					<actual value="153" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="2416" />
					<actual value="341" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="1581" />
					<actual value="196" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="68401" />
					<actual value="69474" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="45045" />
					<actual value="44354" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="34200" />
					<actual value="31246" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="45045" />
					<actual value="53410" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="27361" />
					<actual value="30993" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="34201" />
					<actual value="38228" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="54721" />
					<actual value="58420" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="27360" />
					<actual value="27427" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90090" />
					<actual value="97764" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1208" />
					<actual value="237" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="3162" />
					<actual value="440" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="889" />
					<actual value="212" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="889" />
					<actual value="173" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="2416" />
					<actual value="457" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="1778" />
					<actual value="385" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="1208" />
					<actual value="220" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="1581" />
					<actual value="230" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1581" />
					<actual value="210" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.00" />
					<actual value="81.10" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="74.60" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="75.00" />
					<actual value="70.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="72.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="75.00" />
					<actual value="65.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="80.00" />
					<actual value="69.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="75.00" />
					<actual value="70.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.00" />
					<actual value="81.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="80.00" />
					<actual value="70.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="90.00" />
					<actual value="90.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="90.00" />
					<actual value="94.00" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="90.00" />
					<actual value="93.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="95.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="95.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="90.00" />
					<actual value="93.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="90.00" />
					<actual value="88.40" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="90.00" />
					<actual value="92.90" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="90.00" />
					<actual value="88.40" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for NGA-T-IHVNP05</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="36.00" />
					<actual value="59.59" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="60.00" />
					<actual value="75.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="46.00" />
					<actual value="75.25" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="46.00" />
					<actual value="75.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="60.00" />
					<actual value="75.25" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="80.00" />
					<actual value="80.20" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.00" />
					<actual value="84.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="80.00" />
					<actual value="84.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="74" />
					<actual value="98" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="114" />
					<actual value="169" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="89" />
					<actual value="169" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="90.00" />
					<actual value="123671" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for NGA-T-IHVNP05</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="217" />
					<actual value="217" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="216" />
					<actual value="219" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="214" />
					<actual value="219" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB/HIV mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="15" />
					<actual value="6.2" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="14" />
					<actual value="4.7" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="13" />
					<actual value="4.7" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="4.20" />
					<actual value="2.50" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="4.10" />
					<actual value="5.60" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="4.09" />
					<actual value="5.60" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-NGA-T-IHVN-4</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Investing for impact against Tuberculosis - Nigeria (01-Jan-2019-31-Dec-2020)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Nigeria, Tuberculosis, Institute of Human Virology Nigeria (IHVN)This program has the following goals: To ensure universal access to high-quality, patient-centred, prevention, diagnosis and treatment services for TB, TB/HIV and DR-TB by 2020..  Responsive and resilient health systems that promote universal access to quality health care services by 2020. The objectives of this program are: To increase case notification rate of all forms of TB from 55.1/100,000 population in 2017 to 287 per 100,000 population in 2020.  To increase TB treatment success rate from 85% in 2017 to 90% in 2020 among drug susceptible patients.  To enrol 100% of diagnosed DR-TB patients on appropriate treatment by 2020.  Strengthen health systems for delivery of packages of essential health care services</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<other-identifier ref="NGA-T-IHVNP04" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2019-01-01" />
		<activity-date type="2" iso-date="2019-01-01" />
		<activity-date type="3" iso-date="2020-12-31" />
		<activity-date type="4" iso-date="2020-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Jean, NOUBOUSSI</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>jean.nouboussi@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="NG" percentage="100">
			<narrative xml:lang="en">Nigeria</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12110" percentage="10">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="3">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="87">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="10">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="75">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2020-01-01" />
			<period-end iso-date="2020-12-31" />
			<value currency="USD" value-date="2019-01-01">40333432.00</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2019-01-01" />
			<period-end iso-date="2019-12-31" />
			<value currency="USD" value-date="2019-01-01">15659025.56</value>
		</budget>
		<transaction ref="6990a4be-62c7-4d05-bbae-10f02fc26a94">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-10-18" />
			<value currency="USD" value-date="2021-10-18">-1367.61</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b93c3914-dcb5-4be0-853e-33246dcc4c67">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-09-29" />
			<value currency="USD" value-date="2022-09-29">-80694.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0809e889-6414-4973-9c29-4539402a16c8">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-04-01" />
			<value currency="USD" value-date="2020-04-01">6985526.81</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fb6e7c1f-5893-49fa-bba8-d4734b067451">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-06-16" />
			<value currency="USD" value-date="2020-06-16">23148177.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6142e470-75e9-4012-befd-e68695bc5e55">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-04-01" />
			<value currency="USD" value-date="2020-04-01">-5453984.60</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5e1a358e-a8f5-47bf-93d6-1d598268cb9f">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-02-14" />
			<value currency="USD" value-date="2019-02-14">27024037.51</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e5fb3d7a-44b4-42a7-b113-5f76494b907f">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-11-23" />
			<value currency="USD" value-date="2022-11-23">-3191529.38</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c914c83f-765e-473f-8227-3a7c0f19cbc2">
			<transaction-type code="7" />
			<transaction-date iso-date="2021-10-01" />
			<value currency="USD" value-date="2021-10-01">-1367.61</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="22d3030f-1a05-4002-81e6-9105c14719ca">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-09-02" />
			<value currency="USD" value-date="2020-09-02">21110.60</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="46fee017-9fbd-4d9a-bbbf-73bbd1e5eb6d">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-02-19" />
			<value currency="USD" value-date="2021-02-19">7672.50</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8855e32f-aaf3-466b-ae88-1435587f8739">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-11-14" />
			<value currency="USD" value-date="2019-11-14">8990.40</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0df228f7-24e1-4d9b-9d9c-e31a9a17ca3d">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-06-24" />
			<value currency="USD" value-date="2020-06-24">30025.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cd1e8236-364a-40bc-9783-b9e222117971">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-06-20" />
			<value currency="USD" value-date="2019-06-20">164730.69</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e1029b76-a547-42c8-b6be-7c71c6061639">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-09-27" />
			<value currency="USD" value-date="2019-09-27">20964.12</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3a9300ba-b7a4-4925-8609-01cf8e370ce2">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-04-02" />
			<value currency="USD" value-date="2020-04-02">6985526.81</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8e81d398-5630-4b79-a20e-13c93e3d462a">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-02-19" />
			<value currency="USD" value-date="2019-02-19">3530765.91</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6b9585ea-452d-46be-8144-06826120d667">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-12-16" />
			<value currency="USD" value-date="2020-12-16">1798711.23</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f6580319-5326-4e51-8366-0924da829f8a">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-09-02" />
			<value currency="USD" value-date="2020-09-02">4946659.29</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d01c8060-1b42-4b57-a9d8-7d915c069fb8">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-05-16" />
			<value currency="USD" value-date="2019-05-16">9561154.48</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="03107ec8-4f2c-46ac-8040-05d40dfb0906">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-12-17" />
			<value currency="USD" value-date="2019-12-17">3036818.12</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1048ed61-d56e-4195-9e18-c38329bf923d">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-10-10" />
			<value currency="USD" value-date="2019-10-10">5246629.19</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="659c9fe9-cdd5-4ad6-b459-9e6851b8d18b">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-06-24" />
			<value currency="USD" value-date="2020-06-24">13152469.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="27e287ac-fccd-43a6-b3ff-e8560f975afe">
			<transaction-type code="7" />
			<transaction-date iso-date="2022-09-26" />
			<value currency="USD" value-date="2022-09-26">-80694.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP04.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/NGA-T-IHVN" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for NGA-T-IHVNP04</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="89517" />
					<actual value="30570" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="44759" />
					<actual value="9806" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="35498" />
					<actual value="5863" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="70995" />
					<actual value="13462" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="2929" />
					<actual value="310" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="1465" />
					<actual value="161" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="2323" />
					<actual value="191" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="1162" />
					<actual value="145" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="2207" />
					<actual value="265" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="1104" />
					<actual value="153" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="1392" />
					<actual value="190" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="2783" />
					<actual value="394" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.00" />
					<actual value="85.50" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="90.00" />
					<actual value="83.00" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="90.00" />
					<actual value="85.00" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="90.00" />
					<actual value="82.00" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for NGA-T-IHVNP04</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB/HIV mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="17" />
					<actual value="14" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="210" />
					<actual value="219" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="4.10" />
					<actual value="4.3" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for NGA-T-IHVNP04</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="90.00" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.00" />
					<actual value="88" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="80.00" />
					<actual value="77.00" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="85.00" />
					<actual value="78" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-NGA-T-IHVN-2</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Tuberculosis - Nigeria (01-Jan-2013-31-Dec-2015)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Nigeria, Tuberculosis, Institute of Human Virology Nigeria (IHVN)</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">Institute of Human Virology Nigeria</narrative>
		</participating-org>
		<other-identifier ref="NGA-T-IHVNP02" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2013-01-01" />
		<activity-date type="2" iso-date="2013-01-01" />
		<activity-date type="3" iso-date="2015-12-31" />
		<activity-date type="4" iso-date="2015-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Jean, NOUBOUSSI</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>jean.nouboussi@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="NG" percentage="100">
			<narrative xml:lang="en">Nigeria</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12263" percentage="100">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<transaction ref="03032aa0-09fc-4179-900c-b6969cac3f3a">
			<transaction-type code="2" />
			<transaction-date iso-date="2015-12-18" />
			<value currency="USD" value-date="2015-12-18">-6629985.09</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1f204278-1a7d-44c2-ba8a-dd856423f9b5">
			<transaction-type code="2" />
			<transaction-date iso-date="2015-11-30" />
			<value currency="USD" value-date="2015-11-30">12202.92</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="652ad2f3-30df-4c02-982f-932c66597276">
			<transaction-type code="2" />
			<transaction-date iso-date="2015-10-08" />
			<value currency="USD" value-date="2015-10-08">17904092.34</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="070d564d-ee3f-4078-aded-7d21a9ce9ad3">
			<transaction-type code="2" />
			<transaction-date iso-date="2014-05-01" />
			<value currency="USD" value-date="2014-05-01">-282343.05</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ca3b480c-e7a3-4b1e-80f9-f2f1d1484305">
			<transaction-type code="2" />
			<transaction-date iso-date="2014-01-10" />
			<value currency="USD" value-date="2014-01-10">6381498.24</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="dcf719f1-2cb4-492b-a362-8b98105c693d">
			<transaction-type code="2" />
			<transaction-date iso-date="2014-05-01" />
			<value currency="USD" value-date="2014-05-01">4648768.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="301045ad-d35b-4c6f-9dbf-4335b672abdb">
			<transaction-type code="2" />
			<transaction-date iso-date="2015-10-08" />
			<value currency="USD" value-date="2015-10-08">-47204.15</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="29be41ae-93db-4820-9350-a99523b31f77">
			<transaction-type code="3" />
			<transaction-date iso-date="2015-10-13" />
			<value currency="USD" value-date="2015-10-13">11130453.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="054050ec-bbe5-4f3d-8013-fafec735d439">
			<transaction-type code="3" />
			<transaction-date iso-date="2015-11-30" />
			<value currency="USD" value-date="2015-11-30">12202.92</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="33781bc3-ddd0-4ace-8049-2beb89a2a658">
			<transaction-type code="3" />
			<transaction-date iso-date="2014-08-06" />
			<value currency="USD" value-date="2014-08-06">335442.06</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d2db29c9-5ee3-4b90-8d2f-fb4d904a659b">
			<transaction-type code="3" />
			<transaction-date iso-date="2015-03-23" />
			<value currency="USD" value-date="2015-03-23">2077314.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d75aad7f-ae04-4d9a-ac1e-288aea65c0db">
			<transaction-type code="3" />
			<transaction-date iso-date="2014-12-17" />
			<value currency="USD" value-date="2014-12-17">132921.68</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3ffef76d-f274-4d63-9b2f-e4223869814d">
			<transaction-type code="3" />
			<transaction-date iso-date="2013-09-25" />
			<value currency="USD" value-date="2013-09-25">397254.19</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d903ab91-6bbd-43d0-87fe-05f94dbc0488">
			<transaction-type code="3" />
			<transaction-date iso-date="2014-05-02" />
			<value currency="USD" value-date="2014-05-02">1541890.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="87a085b9-1244-4c85-837c-59f705386aab">
			<transaction-type code="3" />
			<transaction-date iso-date="2014-08-06" />
			<value currency="USD" value-date="2014-08-06">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8964b5c8-5302-4b1c-9bbe-a427d6becabe">
			<transaction-type code="3" />
			<transaction-date iso-date="2014-05-23" />
			<value currency="USD" value-date="2014-05-23">434216.70</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5400e025-46d6-4160-9376-1d1d872d1bd5">
			<transaction-type code="3" />
			<transaction-date iso-date="2013-07-08" />
			<value currency="USD" value-date="2013-07-08">2099809.23</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="13d8a453-f95b-4b6f-9374-b2ac91d3b0cb">
			<transaction-type code="3" />
			<transaction-date iso-date="2013-12-04" />
			<value currency="USD" value-date="2013-12-04">459791.39</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fa561cfa-6135-4d32-a4e8-94460395cade">
			<transaction-type code="3" />
			<transaction-date iso-date="2014-12-08" />
			<value currency="USD" value-date="2014-12-08">29779.41</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8a6bf825-97ce-4cc6-b4d4-e6d665e62a77">
			<transaction-type code="3" />
			<transaction-date iso-date="2013-07-08" />
			<value currency="USD" value-date="2013-07-08">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="31feea7b-6b80-4c6d-b482-b2e45a3879cb">
			<transaction-type code="3" />
			<transaction-date iso-date="2013-10-21" />
			<value currency="USD" value-date="2013-10-21">1894662.38</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e6c648c2-1aaf-4e38-9bb4-be2291a84ac0">
			<transaction-type code="3" />
			<transaction-date iso-date="2013-03-05" />
			<value currency="USD" value-date="2013-03-05">282952.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a0054ed3-bad9-442d-bea1-156a430ee3d1">
			<transaction-type code="3" />
			<transaction-date iso-date="2015-10-13" />
			<value currency="USD" value-date="2015-10-13">143654.25</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1a5ded95-1c02-4277-8fff-a7b6fc05acbb">
			<transaction-type code="3" />
			<transaction-date iso-date="2013-03-05" />
			<value currency="USD" value-date="2013-03-05">914686.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to NGA-T-IHVNP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Institute of Human Virology Nigeria (IHVN)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/NGA-T-IHVN" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
	</iati-activity>
</iati-activities>